我有时会去抑郁症和焦虑症小组观察,看看大家遇到的具体问题是什么。网友 厨子猪跑 在3月27日问 我有时会去抑郁症和焦虑症小组观察,看看大家遇到的具体问题是什么。网友 厨子猪跑 在3月27日问道: “还在上学的(焦虑症)病友,如何应对成绩下滑或保持学习状态? 如题,楼主本科在读,生病之后GPA掉得很厉害,每学期有那么两三门课很喜欢强迫自己去拯救的课可以得很高分,其他的课仿佛完全没有力气去学了,但以前不是这样的,不管是否喜欢都能打起精神学的不错。现在好像丧失了做事情的活力了。 然后会自责而且感到有落差。因为觉得自己原本可以做的比这更好...... 这学期状态更差,上课精神也很不好,每天过得特别难过,经常一在床上躺就躺很久。 真的真的求经验!不管是正在经历相似过程的还是已经走过去的,欢迎分享!” 我并没期望真的能帮上什么忙,因为我知道每个焦虑的人的内心感受可能都会不一样,但是还是抱着应该写点总结的心态试着简要回复了一下: 我曾有一段时间跟你差不多,我在实验室工作,但每天能保持工作两三个小时就不错了,看书的时候经常会惊恐发作。首先我是接受现状了,因为我知道自己认知能力下降了,不能强求学习能力还像以前一样,每天两个小时已经很好了;我拿个小本子写每天必须要做的事事无巨细,做完一项就给自己标个小红花;我练习冥想,惊恐发作的时候就跑到安静的地方发一会呆,听听冥想用的音乐休息一会,等平静下来再回去接着学习。另外,我有服药,药物可能也起到了一定作用。 过了几日楼主回复到: “谢谢分享!真的很需要有这样的病友来分享经验和故事!It really helps!” 看来他/她觉得这些话有用。既然如此,我也转帖在这里。并不是多么仔细地回答,跟我开此帖的原意不符(我是希望系统性地写关于抑郁症的东西)。但是有时候就是快刀斩乱麻,对于一些人,一两句话就能安抚慌乱惊恐的一天。 ... aizzibleoK
后来,换了工作之后,症状更加严重。我开始常常拉扯自己额前的头发,是情不自禁地抓着头发往上拉,因为我几乎每天都头晕,而且持续的时间越来越长,到最后,每天只要醒着就会头晕,拉扯头发可以让我稍微清醒一些。头晕最严重的时候,走路都需要扶着墙。每天都是没睡醒的状态,刚从床上起来,刷牙的时候就可以闭着眼睛睡着。在办公室也是强忍着不打瞌睡,实在忍不住了,就跑厕所洗个脸,或者干脆在隔间里睡一会。工作总是无法好好完成,一遇到稍微有点麻烦的事情就开始烦躁不安,只能草草做完了事。还有,总是坐不稳站不安。坐着一段时间之后就开始想往地上蹲,控制不住地想往地上坐。只能用臀部上部接近尾龙骨的部分支撑在椅子上坐着,只有这样我才能坐得久一点。站着的时候必须找东西靠着,有时候靠墙上,有时候靠着桌子,否则就会开始烦躁不安,感觉自己马上就会晕过去或者突然猝死一样。另外,我还特别怕吵闹,如果身边的人说话稍微大声一些,就会觉得很烦躁,很想逃离出去。感觉所有的噪声在拼命地往我脑子里钻。那段时间我非常抵触跟别人交谈,不必要的社交也都尽可能推掉,甚至上司请吃饭我都不想去。我开始越来越少说话,因为说多了会累,气接不上(这再次让我怀疑我肾虚)。因此,一整天,如非必要,我绝不开口说话。对于刚换了新工作的我来说,这等于是将自己与所有同事都隔绝开了。因此,每天一上班,我就觉得周围的气氛异常的压抑,大家都很陌生,即使我已经在那里上班超过两个月了,可是,依然无法跟身边的同事好好交流。上班成了一件非常痛苦的事情。

最近忙着写论文,这个贴就被我这么晾着了。还有两个月我就完成大作啦,继续努力~@@!最为偷懒, 最近忙着写论文,这个贴就被我这么晾着了。还有两个月我就完成大作啦,继续努力~@@!最为偷懒,就转自己以前写过的吧。 我发现我的一篇日记总是有人收藏,尤其是最近,平均每几天就有一个人收藏,后台总是给我发来通知。 那就说明这篇帖子的内容是被人需要的,有人在搜索着。 沉默,是会呼吸的痛。我能想象到,在屏幕的那一边,有一个人正在经历着精神上的痛苦,他/她想尽力地帮助自己,不放弃一丝希望。他/她虽什么也没说,但每一天的生活都是真实地痛苦着。 我希望这个帖子能帮助有需要的人好起来。 我相信你能最终好起来。因为至少还有我这样的人,还有很多专业的人士,愿意帮助你。去认识他们,去寻求帮助,你并不孤独。 《长期抑郁该如何治疗?如何预防抑郁症复发?》 https://www.douban.com/note/576926663/ ... aizzibleoK


Manic-depressive or bipolar depression is not as common as other forms of depression. Bipolar disorder used to be known as ‘manic depression’ because in this the person experiences periods of mania and periods of depression, with periods of normal mood in between. About 1% of the population will experience bipolar disorder at some time in their lives. In bipolar disorder cycles of mood swings from mania to depression occur over time. The mood change may have a psychotic basis with delusional thinking or occur in isolation and induce anxiety.
And one of the things that often gets lost in discussions of depression is that you know it's ridiculous. You know it's ridiculous while you're experiencing it. You know that most people manage to listen to their messages and eat lunch and organize themselves to take a shower and go out the front door and that it's not a big deal, and yet you are nonetheless in its grip and you are unable to figure out any way around it. And so I began to feel myself doing less and thinking less and feeling less. It was a kind of nullity.
我第一次接触抑郁量表这个事物也是在2005年。我的班级辅导员带我去精神卫生中心做诊断。从我们的学校到这个地方要做很长一段的地铁。在去程上,辅导员一直在安慰我,说学业压力大不要紧的,这学期少修点课不就可以了吗?等我到达精神卫生中心以后,我记得我在电脑前面做了很多选择题,之后跟医生聊了聊。我的辅导员得到了我的诊断报告,但是她没有告诉我具体信息,只说没什么大碍。回程的路上,她却沉默地一句话都不再跟我说。回到学校之后,她再也不跟我联系,而我的情况却在一天天恶化。她去带我做诊断是应我父亲的要求,她好似仅把这当成是一个任务去完成。后来我办理休学,她也没有帮一点忙。我回忆这段经历的时候,认为她是有失职的。但是随着时间推移,我在情理上原谅了她。我们学校的本科生辅导员是由本校直升硕士一年级新生担任的。我刚刚步入大学校园,对于她,新生活何尝不是也刚刚展开。也许她想的只是怎么完成好组织任务并且自己顺利毕业。让一个对抑郁症没有了解的跟自己非亲非故的人做到更多实在是难为她了。但从学校管理的角度上讲,她没有照顾好她的学生,是失职的。我们的学校,应该给予本科生的辅导员一些心理咨询辅导,让他们具备一些基本的心理健康常识,以便服务他们的学生。后来我的同班同学中也有人在毕业后直升本校硕士研究生,并且担任本科生的辅导员。在我们聚会时,他们有人提到,在连续几届的学生中都有人有抑郁症,其中一届有一个学生在宿舍里上吊自杀。当我听到这样的故事时,心中一声叹息。
目的观察抑郁大鼠电休克治疗后海马内谷氨酸含量以及N-甲基-D天门冬氨酸(NMDA)受体 的表达,探讨电休克治疗抑郁症的谷氨酸能神经机制。方法36只SD大鼠随机分为无抽搐电休克组(电休克组)、抑郁模型对照组(抑郁组)、对照组,每组12 只。前两组采用孤养加慢性不可预见性应激建立抑郁模型,建模后电休克组在丙泊酚麻醉下行无抽搐电休克治疗,隔天1次共2周。检测各组海马谷氨酸含量和海马 CA1区、CA3区NMDA受体2B亚单位(NMDA-NP,2B)的表达。结果①电休克治疗后电休克组大鼠水平移动格数、垂直竖立次数和糖水消耗量都高 于抑郁组(P〈0.01)。②电休克组大鼠海马内谷氨酸含量低于抑郁组(P〈0.01),而抑郁组高于正常组(P〈0.01)。③电休克组大鼠海马CAI 区和CA3区NMDA.NP,2B的表达量高于正常组(P〈0.05),而抑郁组低于正常组(P〈0.01)。结论无抽搐电休克治疗可抑制抑郁症模型大鼠 海马内谷氨酸含量的升高并使NMDA—NR2B的表达量上调,这可能是其抗抑郁机制之一。

BACKGROUND: In 2001, the Canadian Psychiatric Association and the Canadian Network for Mood and Anxiety Treatments (CANMAT) partnered to produce evidence-based clinical guidelines for the treatment of depressive disorders. A revision of these guidelines was undertaken by CANMAT in 2008-2009 to reflect advances in the field. There is renewed interest in refined approaches to brain stimulation, particularly for treatment resistant major depressive disorder (MDD). METHODS: The CANMAT guidelines are based on a question-answer format to enhance accessibility to clinicians. An evidence-based format was used with updated systematic reviews of the literature and recommendations were graded according to Level of Evidence using pre-defined criteria. Lines of Treatment were identified based on criteria that included evidence and expert clinical support. This section on "Neurostimulation Therapies" is one of 5 guidelines articles. RESULTS: Among the four forms of neurostimulation reviewed in this section, electroconvulsive therapy (ECT) has the most extensive evidence, spanning seven decades. Repetitive transcranial magnetic (rTMS) and vagus nerve stimulation (VNS) have been approved to treat depressed adults in both Canada and the United States with a much smaller evidence base. There is also emerging evidence that deep brain stimulation (DBS) is effective for otherwise treatment resistant depression, but this is an investigational approach in 2009. LIMITATIONS: Compared to other modalities for the treatment of MDD, the data based is limited by the relatively small numbers of randomized controlled trials (RCTs) and small sample sizes. CONCLUSIONS: There is most evidence to support ECT as a first-line treatment under specific circumstances and rTMS as a second-line treatment. Evidence to support VNS is less robust and DBS remains an investigational treatment.
经颅磁刺激技术(transcranial magnetic stimulation,TMS)即以磁信号刺激颅脑神经方式达到神经功能改善目的。TMS在1985应用于临床治疗,随着技术的发展与革新,出现具有连续可调功能的重复TMS(repetitive transcranial magnetic stimulation,rTMS),并在临床精神病、神经疾病及康复领域获得越来越多的认可。低频和高频rTMS均能有效治疗抑郁症,二者效果相当,但前者耐受性更好,适应人群更广泛,故目前抑郁症治疗中主要采用低频rTMS。2016年美国临床经颅刺激学会发布的TMS治疗重度抑郁症共识[22]指出,每日左前额TMS治疗急性期抑郁症患者安全有效。该共识认为,对于临床诊断符合DSM-5定义的抑郁症,单次发作或复发性抑郁症、抗抑郁症药物治疗效果不佳或不耐受的患者,应考虑单独或合并TMS治疗。TMS在急性期及急性期后治疗中均有良好效果,并且急性期后持续TMS治疗可降低抑郁症复发风险。
最近忙着写论文,这个贴就被我这么晾着了。还有两个月我就完成大作啦,继续努力~@@!最为偷懒, 最近忙着写论文,这个贴就被我这么晾着了。还有两个月我就完成大作啦,继续努力~@@!最为偷懒,就转自己以前写过的吧。 我发现我的一篇日记总是有人收藏,尤其是最近,平均每几天就有一个人收藏,后台总是给我发来通知。 那就说明这篇帖子的内容是被人需要的,有人在搜索着。 沉默,是会呼吸的痛。我能想象到,在屏幕的那一边,有一个人正在经历着精神上的痛苦,他/她想尽力地帮助自己,不放弃一丝希望。他/她虽什么也没说,但每一天的生活都是真实地痛苦着。 我希望这个帖子能帮助有需要的人好起来。 我相信你能最终好起来。因为至少还有我这样的人,还有很多专业的人士,愿意帮助你。去认识他们,去寻求帮助,你并不孤独。 《长期抑郁该如何治疗?如何预防抑郁症复发?》 https://www.douban.com/note/576926663/ ... aizzibleoK
是由两种非常有效的化合物组成的合剂。三氟噻吨是一种神经阻滞剂,根据不同剂量具有不同药理作用。大剂量的三氟噻吨主要拮抗突触后膜的多巴胺受体,降低多巴胺能活性 ;而小剂量三氟噻吨主要作用于突触前膜多巴胺自身调节受体(D2受体),促进多巴胺的合成和释放,使突触间隙中多巴胺的含量增加,而发挥抗焦虑和抗抑郁作用。四甲蒽丙胺是一种双相抗抑郁剂,可以抑制突触前膜对去甲肾上腺素及5-羟色胺的再摄取作用,提高了突触间隙的单胺类递质的含量。两种成分的合剂具有协同的调整中枢神经系统的功能,抗抑郁、抗焦虑和兴奋特性。另一方面,本药中的四甲蒽丙胺可以对抗大剂量时三氟噻吨可能产生的锥体外系症状。三氟噻吨和四甲蒽丙胺相互拮抗的结果使本药的抗胆碱能作用较四甲蒽丙胺弱。本药对上述中枢神经递质的影响,临床上也相应表现为两种成分在治疗作用方面的协同效应和副作用的拮抗效应。此外,体内及体外试验表明,本药对组胺受体有一定的拮抗作用。并且还具有镇痛、抗惊厥作用,但无抗精神病作用。
4.3.4 共病性抑郁 综合医院患者躯体疾病伴发或共病焦虑、抑郁较为常见,如脑卒中、帕金森综合征、老年性痴呆、冠心病、糖尿病、慢性阻塞性肺疾病、恶性肿瘤等。部分心血管药物(如可乐定、利舍平、β受体阻断药)、中枢神经系统药物(如巴比妥类、苯二氮类、苯妥英)、激素类药物(如皮质醇激素、雌激素、黄体酮)及吲哚美辛、干扰素、麻醉剂等在治疗过程中也可引起抑郁症。原发疾病或药物可导致抑郁症,反之,持续存在的抑郁症又影响原发疾病的预后与转归,二者相互促进,关系复杂。临床工作中应注意识别和区分原发疾病本身表现和共病性抑郁,积极应用量表综合评估,这点已成为国内专家共识[19]。症状较轻者可给予健康教育和心理支持治疗;中重度抑郁症建议精神科会诊或转诊。共病性抑郁症治疗关键在于早期识别和介入,积极治疗原发病及去除可能心理、药物因素。抗抑郁症药物共病性抑郁症患者与一般抑郁人群无明显差别,但应注意药物相互作用及不良反应。我国专家共识[19]建议,卒中后抑郁症可考虑选择西酞普兰、舍曲林、艾司西酞普兰等SSRIs类及TCAs中的阿米替林等药物;痴呆患者可选择抗胆碱能作用小的药物,如安非他酮、氟西汀、舍曲林、曲唑酮;帕金森综合征患者可考虑选择帕罗西汀及文拉法辛,不加重帕金森综合征的运动症状;合并心血管疾病可选择SSRIs、SNRIs、安非他酮等,但需注意QT间期延长风险;合并糖尿病患者可选择能减少对胰岛素抵抗的SSRIs;癌症患者可以选择疗效较肯定的SSRIs和SNRIs;躯体疼痛症状明显者,建议优先选择对疼痛疗效好且不良反应小的SNRIs。
As clinicians, we routinely make critical decisions for our patients with depression. Because of the uncertainty of factors that affect diagnosis and treatment, clinicians may find an objective, quick measurement tool helpful. Measurementbased care (MBC) provides specific and objective information on which to base clinical decisions and should therefore enhance quality of care and treatment outcomes. (1-3) MBC rests on these assumptions. * Compared with general questions that are typically asked during a patient evaluation, specific measurements (administered by clinicians or self-reported by patients) provide more accurate information on which to establish a diagnosis, assess treatment outcomes, and modify treatments. * Patients who complete these measurement tests will better understand their disorder and treatment effects, which will enable them to better manage their depression. * Medical records that include the results of specific measurements will assist subsequent clinicians in understanding the results of prior treatments. * The routine use of the same measurements in practice and clinical research studies will help clinicians translate research findings into their own practices. * For most outpatients with depression, self-report methods are available that are free and that take little time and effort. Diagnostic measurements Researchers have used criterion-based diagnostic methods for years. After DSM-III was introduced in 1980, the Structured Clinical Interviews for DSM-III (SCID) (and later for DSMIV) were developed to obtain lifetime diagnoses. (4,5) Briefer structured interviews were then developed, including the Mini-International Neuropsychiatric Interview (MINI), which assesses only current diagnoses, and the MINI-Plus, which elicits information about current and past diagnoses. (6-8) The MINI takes 30 to 40 minutes to administer, while the MINI-Plus may take up to 60 minutes. Studies have shown that structured or semistructured interviews provide more accurate diagnoses than typical practice. For example, clinically rendered diagnoses were compared with those made based on SCID results. (9) Major diagnostic differences were found in 40% of outpatients with clinical diagnoses of schizophrenia or bipolar or major depressive disorders. In addition, when clinicians were provided with a diagnosis that was determined using SCID, they changed the chart diagnosis in a substantial proportion of cases and prescribed fewer medications. (10) Symptom measurements Once a diagnosis has been made and therapy has been initiated, the regimen must often be modified because of intolerance, adverse effects, or other less-than-desirable symptomatic outcomes. Medication and somatic therapies are typically aimed at treating symptoms, but psychotherapy and disease self-management may also address other aspects of treatment (eg, medication adherence, social/occupational function, self-esteem). The Texas Medication Algorithm Project (TMAP) and the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) studies showed that diligent assessment of symptoms and adverse effects enhances outcomes. (11-14) The goal of therapy for depression is symptom remission and, ultimately, sustained remission and functional recovery. (15) Most patients require more than 1 treatment revision (eg, altered dosage, treatment, or delivery). When implementing guideline-driven or evidencebased care, initial treatment is continued until remission or maximal symptom improvement is obtained or until the patient cannot tolerate the regimen. Thereafter, the dosage or type of treatment may...
是由两种非常有效的化合物组成的合剂。三氟噻吨是一种神经阻滞剂,根据不同剂量具有不同药理作用。大剂量的三氟噻吨主要拮抗突触后膜的多巴胺受体,降低多巴胺能活性 ;而小剂量三氟噻吨主要作用于突触前膜多巴胺自身调节受体(D2受体),促进多巴胺的合成和释放,使突触间隙中多巴胺的含量增加,而发挥抗焦虑和抗抑郁作用。四甲蒽丙胺是一种双相抗抑郁剂,可以抑制突触前膜对去甲肾上腺素及5-羟色胺的再摄取作用,提高了突触间隙的单胺类递质的含量。两种成分的合剂具有协同的调整中枢神经系统的功能,抗抑郁、抗焦虑和兴奋特性。另一方面,本药中的四甲蒽丙胺可以对抗大剂量时三氟噻吨可能产生的锥体外系症状。三氟噻吨和四甲蒽丙胺相互拮抗的结果使本药的抗胆碱能作用较四甲蒽丙胺弱。本药对上述中枢神经递质的影响,临床上也相应表现为两种成分在治疗作用方面的协同效应和副作用的拮抗效应。此外,体内及体外试验表明,本药对组胺受体有一定的拮抗作用。并且还具有镇痛、抗惊厥作用,但无抗精神病作用。
And finally one day, I woke up and I thought perhaps I'd had a stroke, because I lay in bed completely frozen, looking at the telephone, thinking, "Something is wrong and I should call for help," and I couldn't reach out my arm and pick up the phone and dial. And finally, after four full hours of my lying and staring at it, the phone rang, and somehow I managed to pick it up, and it was my father, and I said, "I'm in serious trouble. We need to do something." 
×